Status:

COMPLETED

Glutamine for the Treatment of Patients With Irritable Bowel Syndrome

Lead Sponsor:

Tulane University

Conditions:

Diarrhea-Predominant Irritable Bowel Syndrome

Eligibility:

All Genders

18-72 years

Phase:

PHASE2

Brief Summary

New and effective treatments are needed for patients with post-infectious irritable bowel syndrome (PI-IBS). We conducted a randomized, placebo-controlled trial to assess the efficacy and safety of gl...

Detailed Description

In a double-blind trial, eligible adults with post-infectious IBS with increased intestinal permeability were randomly assigned to receive either glutamine (5 g three times daily) or placebo for eight...

Eligibility Criteria

Inclusion

  • men and women age 18-72 years old who developed post-infectious diarrhea-predominant IBS (D-IBS)
  • increased intestinal permeability on Lactulose/Mannitol permeability test
  • able and willing to cooperate with the study
  • \*absence of alcohol or NSAIDs ingestion for 2 weeks prior to inclusion into study and throughout the study duration

Exclusion

  • current participation in another research protocol or unable to give informed consent
  • women with a positive urine pregnancy test or breastfeeding
  • history of inflammatory bowel disease, lactose intolerance, and/or celiac sprue
  • \+ hydrogen breath test for bacterial overgrowth
  • \+ antiendomysial antibody titer
  • use of nonsteroidal antinflammatory drug(NSAIDs) 2 weeks before or during the study
  • known allergy to glutamine
  • abdominal surgery except for removal of gallbladder, uterus, or appendix
  • Abnormal blood urea nitrogen(BUN) and/or creatinine

Key Trial Info

Start Date :

November 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 30 2015

Estimated Enrollment :

106 Patients enrolled

Trial Details

Trial ID

NCT01414244

Start Date

November 1 2010

End Date

December 30 2015

Last Update

August 9 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tulane University School of Medicine

New Orleans, Louisiana, United States, 70112